Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2012 - 2026)

Dr Reddys Laboratories' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $549.8 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 4.67% year-over-year to $549.8 million; the TTM figure through Mar 2026 stood at $549.8 million (up 4.67% YoY), while the FY2026 annual figure was $569.4 million, up 5.81% from the prior year.
• Other Accumulated Expenses was $549.8 million for Q1 2026 at Dr Reddys Laboratories, up from $536.1 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $549.8 million in Q1 2026 to a low of $417.8 million in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $491.3 million across 5 years, with a median of $499.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses gained 1.34% in 2022, then grew 12.32% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $417.8 million in 2022, then gained by 6.39% to $444.5 million in 2023, then increased by 12.32% to $499.3 million in 2024, then grew by 7.39% to $536.1 million in 2025, then advanced by 2.54% to $549.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $549.8 million (Q1 2026), $536.1 million (Q3 2025), and $525.3 million (Q1 2025), per Business Quant data.